Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Clasificación en acciones #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Precio por acción
$0.158
Última sincronización: 2026-04-06
Capitalización bursátil
$302.92K
Cambio (1 día)
16.18%
Cambio (1 año)
-97.91%
País
US
Comercio Abpro Corporation (ABP)

Categoría

Historial de desdoblamientos de acciones de Abpro Corporation (ABP)
La acción Abpro Corporation (símbolo: ABP) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 14, 2026.
Una acción ABP comprada antes de Aug 14, 2026 equivaldría hoy a 0 acciones ABP.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE